Dispersive-cohesive OVD performs well during all stages of lens removal


One surgeon's preference for an ophthalmic viscosurgical device of 1.6% sodium hyaluronate was reinforced by a study that found it superior to another OVD during phaco and OVD removal

Related Videos
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
Marjorie Rah, OD, PhD, FAAO
Josefina Botta, MD, MSc, at ASCRS 2024
J. Morgan Micheletti, MD, speaks at the 2024 ASCRS meeting
Dr William Wiley of Cleveland Eye Clinic, Northeast Ohio
© 2024 MJH Life Sciences

All rights reserved.